S-Alkylation of an N-protected cysteine ester with a range of -iodoalkyl heterocycles affords 11 novel non-proteinogenic heterocyclic amino acids having a sulfur atom in the backboneheterocycle linker.
Introduction
Amongst the proteinogenic amino acids, there are only two examples of side chains carrying a heterocycle, namely histidine 1 and tryptophan 2 ( Figure 1 ). On the other hand heterocyclic chemistry provides an enormous range of potential heterocyclic systems that might be exploited to replace the imidazole or indole moieties. As part of a programme to explore this possibility, we have previously reported on -amino acids 3 (n = 0, 2, 3) carrying heterocycles in their side chains, including pyridine and isoxazole derivatives but in particular the pyrimidine and purine nucleobases tethered to the backbone with varying length carbon chains. 1, 2 These are potential -PNA monomers, 3, 4 amongst many other possible applications, and are analogues of natural products such as discadenine. 5 They are obtained by stereoselective conjugate radical addition to an optically active methylene oxazolidinone derived from S-methylcysteine, 1 or by stereoselective C-alkylation of an ephedrine-based glycinamide. 2 In pursuit of further variation in the heterocycle-backbone tether and the backbone-to-heterocycle linkage protocol, and to demonstrate diversity in the heterocycle, we report now the preparation of 11 novel heterocyclic amino acids 4 (n = 1, 2, 3) with sulfur-containing tethers, obtained by elaboration of cysteine ( Figure 1) . 6, 7 The strategy adopted (Scheme 1) was to alkylate the side chain sulfur atom of a cysteine derivative with haloalkyl heterocycles; the heterocycles employed were nucleobases
Results and Discussion
The scaffold used for the side chain elaboration was N-tert-butoxycarbonyl-(R)-cysteine ethyl ester 5, easily prepared from commercial (R)-cysteine ethyl ester hydrochloride (Boc2O, iPr2NEt, CH2Cl2, 2 h; 98%). Relevant electrophiles, the -iodoalkyl heterocycles 6 (n = 1, 2, 3), were prepared by two general methods (Scheme 2): (i) Method A, Mitsunobu coupling (iPrO2CN=NCO2i-Pr (DIAD), Ph3P) of -bromoalcohols 7 (2-bromoethanol, 3-bromopropan-1-ol, 4-bromobutan-1-ol) with NH-heterocycles, followed by Finkelstein halide exchange with iodide ion (NaI, Me2CO reflux); 1 or (ii) Method B, phase-transfer N-alkylation (Bu4NI, KOH, K2CO3) of the heterocycle with an ,-dihalide 8 (1,2-dichloroethane, 1,3-dichloropropane, 1,4-dichlorobutane) used as solvent, again followed by halide exchange to generate the N-(-iodoalkyl) derivative. In this way, a range of N-iodoethyl derivatives 9a-h were prepared from 3-benzoyluracil, 3-benzoylthymine, indole, benzimidazole, benzotriazole, N 6 -(tertbutoxycarbonyl)adenine and purine as shown in Figure 2 and Table 1. In the case of Figure 2 . -Iodoalkyl heterocycles 9-11 (9: n = 1; 10: n = 2; 11: n = 3) prepared according to Scheme 2. *using 2-choroethanol rather than 2-bromoethanol; †: impure product obtained; ‡: product assigned as 12a; §: product assigned as 12b.
study. 10 Investigations with 2,3-diaminopropionic acid and 2,4-diaminobutyric acid were curtailed as a suitable protected amino acid alkylation substrate could not be easily obtained. On the other hand, we have indications that our approach will be successful using a protected homocysteine scaffold.
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Conclusions
We have successfully prepared 11 novel heterocyclic -amino acids by S-alkylation of an Nprotected cysteine ester, and demonstrated the orthogonal deprotection that will enable their application in organic synthesis.
Experimental Section
General. Flash column chromatography was performed using silica gel 60 (40-63 μ, 230-400 mesh, 60 A), and thin layer chromatography (TLC) performed on Merck 0.2 mm silica 60 F254 coated UV active aluminium sheets. Melting Points were measured on a Stuart Scientific Bibby SMP3 Melting Point Apparatus and IR spectra were recorded on a Perkin-Elmer Paragon 1000 FTIR spectrometer for neat samples on NaCl discs (CH2Cl2 used as a 'transport' solvent where necessary).
1 H NMR spectra were recorded at 400 MHz on a Bruker DPX-400 instrument or at 250 MHz on a Bruker AC-250 instrument; 13 C NMR spectra were recorded at 100 MHz on the Bruker DPX-400 instrument. Chemical shifts are quoted as  ppm with TMS as internal standard, and the coupling constants J in Hz. Signals are described as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad). Mass spectra were recorded using either EI or FAB ionisation, on a JEOL SX102 spectrometer at Loughborough University or by the ESPRC National Mass Spectrometry Service Centre at Swansea University. Liquid ChromatographyMass Spectrometry was performed using a Waters 600 Controller instrument, a Waters Symmetry C8 3.5 μm 4.6 x 50 nm column and a Waters 996 photodiode array detector attached to a Micromass Platform mass spectrometer using electrospray ionization. Elemental Analyses for C, H and N were obtained using a Perkin-Elmer CHN-2400 Elemental Analyzer. 2-Bromoethanol, 2-chloroethanol, 3-bromopropan-1-ol, 4-bromobutan-1-ol, 1,2-dichloroethane, 1,3-dichloropropane, 1,4-dichlorobutane, uracil, thymine, indole, benzimidazole, benzotriazole, adenine, purine and (R)-cysteine ethyl ester were purchased from either Aldrich, Lancaster or Avocado and were used without purification unless otherwise stated. 3-Benzoyluracil and 3-benzoylthymine were prepared according to the method of Reese et al. 12 Solvents were dried where necessary, as follows: THF was pre-dried in the presence of solid K2CO3 then distilled from sodium metal and benzophenone under a positive atmosphere of nitrogen; EtOAc was distilled over calcium chloride; CH2Cl2 was distilled over anhydrous calcium hydride; and 1,4-General procedure C. Halide exchange to afford -iodoalkyl heterocycles (9-11) N-(-Haloalkyl) heterocycle (1 mol equiv) and dry sodium iodide (5 mol equiv) were heated in dry acetone (50 mL per mmol of heterocycle) at reflux overnight in the dark under a nitrogen atmosphere. After cooling, the acetone was removed under reduced pressure and the residue taken up in EtOAc : water (1:1 v/v), the organic layer was separated and the aqueous layer was extracted twice more with EtOAc. The combined organic layers were washed twice with sodium thiosulfate solution (2% w/v), dried (MgSO4), filtered and the solvent was removed under reduced pressure to yield the pure iodoalkyl compound. 3-Benzoyl-1-(2-bromoethyl)uracil. Prepared according to method A as previously reported, using 3-benzoyluracil (5.00 g, 23.04 mmol), triphenylphosphine (7.24 g, 27.63 mmol) and 2-bromoethanol (1.96 mL, 3.45 g, 27.62 mmol) in dry dioxane (100 mL) at 5 C with DIAD (5.43 cm 3 . Data as for material prepared using method B. N 1 -(2-Iodoethyl)benzimidazole (9d). Prepared according to general procedure C, using N 1 -(2-chloroethyl)benzimidazole (2.00 g, 11.08 mmol) and dry NaI (8.12 g, 54.13 mmol) in dry acetone (100 mL). Work up gave the title compound as a pale yellow solid (2.12 g, 72%), IR (max (NaCl/cm N 9 -(2-Iodoethyl)-6-tert-butoxycarbonylaminopurine (9g) . Prepared according to general procedure C, using N 9 -(2-bromoethyl)-6-tert-butoxycarbonylaminopurine (1.60 g, 4.68 mmol) and dry NaI (3.50 g, 23.33 mmol) in dry acetone (100 mL). Work up gave the title compound as a pale yellow oil (0.92 g, 51%), IR (max, NaCl/cm 
Attempted preparation of N 1 -(3-iodopropyl)benzimidazole (10c): Quaternary salt (12a)
Attempted according to general procedure C, using N 1 -(3-bromopropyl)benzimidazole and (1.00 g, 4.18 mmol) and dry NaI (3.15 g, 21.00 mmol) in dry acetone (100 mL), and also by using N 1 -(3-chloropropyl)benzimidazole (1.00 g, 5.14 mmol) and dry NaI (3.86 g, 25.73 mmol) in dry acetone (100 mL). Work up in both cases did not give the title compound, but gave what is provisionally assigned as the dimeric quaternary salt 12a. 1 3 .56 (2H, t, J = 6.2 Hz, CH2Cl), 4.89 (2H, t, J = 6.5 Hz, CH2N), 7.35, 7.84 (each 2H, m, Ar-H). 13 N 1 -(3-Iodopropyl)benzotriazole (10e) . Prepared according to general procedure C, using N 1 -(3-chloropropyl)benzotriazole (1.50 g, 7.67 mmol) and dry NaI (6.19 g, 41.27 mmol) in dry acetone (100 mL). Work up gave the title compound as a pale yellow solid (1. 
N-tert-butoxycarbonyl-(R)-cysteine ethyl ester (5).
To a dry round-bottomed flask was added (R)-cysteine ethyl ester hydrochloride (10.00 g, 53.86 mmol), di-tert-butyl dicarbonate (11.76 g, 53.94 mmol) and diisopropylethylamine (11.18 mL, 8.30 g, 64.31 mmol) in dry CH2Cl2 (200 mL). The mixture was stirred for 2 h at 20 °C and then washed with hydrochloric acid (1M; 2 x 100 mL), NaHCO3 solution (1M; 2 x 100 ml), and water (2 x 100 mL), dried (MgSO4), and the solvent removed under reduced pressure. Work up gave the title compound as off white oil (12.62 
